Peter Friedmann to Recurrence
This is a "connection" page, showing publications Peter Friedmann has written about Recurrence.
Connection Strength
0.302
-
Nunes EV, Gordon M, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hu MC, Boney TY, Wilson D, O'Brien CP. Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. J Subst Abuse Treat. 2018 02; 85:49-55.
Score: 0.120
-
Friedmann PD, Wilson D, Hoskinson R, Poshkus M, Clarke JG. Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison. J Subst Abuse Treat. 2018 02; 85:45-48.
Score: 0.120
-
Murphy SM, Polsky D, Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Bonnie RJ, Gordon M, Chen DT, Boney TY, O'Brien CP. Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction. 2017 Aug; 112(8):1440-1450.
Score: 0.030
-
Johnson JE, Friedmann PD, Green TC, Harrington M, Taxman FS. Gender and treatment response in substance use treatment-mandated parolees. J Subst Abuse Treat. 2011 Apr; 40(3):313-21.
Score: 0.020
-
Kertesz SG, Horton NJ, Friedmann PD, Saitz R, Samet JH. Slowing the revolving door: stabilization programs reduce homeless persons' substance use after detoxification. J Subst Abuse Treat. 2003 Apr; 24(3):197-207.
Score: 0.011